Camber’s generic Viread launches
Camber Pharmaceuticals has launched its generic Viread (tenofovir disoproxil fumarate) tablets. The drug is indicated to treat Hepatitis B and HIV infection.
Camber’s generic Viread will be available in 30-count tablets of 300-mg dosage strength tablets. The product had U.S. sales of roughly $725 million for the 12 months ended November 2017, according to IQVIA data.
Camber’s generic Viread will be available in 30-count tablets of 300-mg dosage strength tablets. The product had U.S. sales of roughly $725 million for the 12 months ended November 2017, according to IQVIA data.